Neoadjuvant chemotherapy with high-dose methotrexate in osteosarcoma.
Mir
Olivier
O
Université Paris Descartes, Faculté de Médecine, Assistance Publique - Hôpitaux de Paris, Paris, France.
Ropert
Stanislas
S
Goldwasser
François
F
D000964:Antimetabolites, Antineoplastic / Q000008:administration & dosage* / Q000266:history; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001859:Bone Neoplasms / Q000188:drug therapy* / Q000266:history; D004334:Drug Administration Schedule; D049673:History, 20th Century; D006801:Humans; D008727:Methotrexate / Q000008:administration & dosage* / Q000266:history; D020360:Neoadjuvant Therapy / Q000266:history / Q000379:methods; D012516:Osteosarcoma / Q000188:drug therapy* / Q000266:history; D015996:Survival Rate; D016896:Treatment Outcome
D000964:Antimetabolites, Antineoplastic; D008727:Methotrexate